What are the benefits of dual antiplatelet therapy after stroke or transient ischemic attack?
According to the systematic review and meta-analysis of randomized clinical trials that was conducted by Patti G et al., dual antiplatelet therapy (clopidogrel and aspirin) has been found to be beneficial in reducing the risk of disabling stroke after a stroke or transient ischemic attack. Furthermore, a study by Amarenco P et al. found that the addition of ticagrelor to aspirin further reduced the risk of disabling stroke. Therefore, dual antiplatelet therapy is beneficial in reducing the risk of disabling stroke after a stroke or transient ischemic attack. 